A new study published in the New England Journal of Medicine reveals that Pfizer’s mRNA-based flu vaccine, known as modRNA, has outperformed traditional flu...
The Food and Drug Administration (FDA) has introduced a new pathway for custom gene editing therapies aimed at treating patients with serious diseases. Announced...
A recent clinical trial has revealed that Eli Lilly’s once-weekly insulin, efsitoria, offers comparable glycemic control to the traditional daily insulin glargine for patients...